Anti-Integrin beta 7 antibody [EP5948]
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(1 Publication)
Rabbit Recombinant Monoclonal Integrin beta 7 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
Integrin beta-7, Gut homing receptor beta subunit, ITGB7
- IP
Lab
Immunoprecipitation - Anti-Integrin beta 7 antibody [EP5948] (AB137058)
purifiedab137058 at 1/50 dilution (2μg) immunoprecipitating Integrin beta 7 in IM-9 whole cell lysate.
Lane 1 (input) : IM-9 (Human multiple myeloma B Lymphoblast) whole cell lysate 10μg
Lane 2 (+) : ab137058 + IM-9 whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab137058 in IM-9 whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 100-120 kDa
All lanes:
Immunoprecipitation - Anti-Integrin beta 7 antibody [EP5948] (ab137058)
Predicted band size: 87 kDa
false
- WB
Unknown
Western blot - Anti-Integrin beta 7 antibody [EP5948] (AB137058)
All lanes:
Western blot - Anti-Integrin beta 7 antibody [EP5948] (ab137058) at 1/1000 dilution
All lanes:
IM-9 cell lysate at 10 µg
Secondary
All lanes:
HRP labeled Goat anti-Rabbit IgG at 1/2000 dilution
Predicted band size: 87 kDa
false
Related conjugates and formulations (2)
-
Anti-Integrin beta 7 antibody [EP5948] - Low endotoxin, Azide free
-
Anti-Integrin beta 7 antibody [EP5948] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Integrin beta 7 facilitates cell adhesion and signaling processes important for immune surveillance and inflammation regulation. As part of heterodimer complexes like α4β7 and αEβ7 integrins it mediates adhesion of lymphocytes to mucosal tissues. This interaction is necessary for directing lymphocytes to sites of inflammation in the intestinal tract. The α4β7 integrin particularly binds to the addressin MAdCAM-1 which is expressed on high endothelial venules in the gut-associated lymphoid tissues.
Pathways
Integrin beta 7 is involved in both integrin-mediated signaling and leukocyte extravasation pathways. These pathways regulate the localization and migration of immune cells to target tissues which is essential for efficient immune responses. The protein works together with integrin alpha 4 and alpha E components to facilitate these processes. Integrin signaling activates various intracellular cascades including those involving kinases that modulate cell adhesion and migration.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 26: PubMed40806782
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com